Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Bane

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Breast Cancer|March 12, 2013
Ductal carcinoma in situ: what the pathologist needs to know and whyAnita Bane
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 18, 2017
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancerDiane Ojo, Ying Wu, Anita Bane, et al.
Rare Tumors|October 23, 2012
Giant cell temporal arteritis associated with overlying basal cell carcinoma: co-incidence or connection?Etienne Mahe, Dina El Demellawy, Anita Bane, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 21, 2004
Linear IgA disease presenting as desquamative gingivitis: a pattern poorly recognized in medicineEsther O'Regan, Anita Bane, Stephen Flint, et al.
Rare Tumors|August 13, 2015
Amelanotic Melanoma Presenting with Plasmacytoid Morphology and BRAF V600 MutationLinda Kocovski, Anita Bane, Shangguo Tang, et al.
Scientific Reports|May 1, 2019
Downregulation of CYB5D2 is associated with breast cancer progressionDiane Ojo, David Rodriguez, Fengxiang Wei, et al.
Scientific Reports|February 23, 2012
A gene signature for predicting outcome in patients with basal-like breast cancerRobin M Hallett, Anna Dvorkin-Gheva, Anita Bane, et al.
Cancer Letters|April 8, 2018
Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancerDiane Ojo, Xiaozeng Lin, Ying Wu, et al.
Nature Reviews. Clinical Oncology|September 30, 2009
Breast cancer in a BRCA2 mutation carrier with a history of prostate cancerSeema Panchal, Orli Shachar, Frances O'Malley, et al.
Breast Cancer Research and Treatment|July 2, 2013
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancersAnita Bane, Alicia Viloria-Petit, Dushanthi Pinnaduwage, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Breast Cancer|March 12, 2013
Ductal carcinoma in situ: what the pathologist needs to know and whyAnita Bane
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 18, 2017
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancerDiane Ojo, Ying Wu, Anita Bane, et al.
Rare Tumors|October 23, 2012
Giant cell temporal arteritis associated with overlying basal cell carcinoma: co-incidence or connection?Etienne Mahe, Dina El Demellawy, Anita Bane, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 21, 2004
Linear IgA disease presenting as desquamative gingivitis: a pattern poorly recognized in medicineEsther O'Regan, Anita Bane, Stephen Flint, et al.
Rare Tumors|August 13, 2015
Amelanotic Melanoma Presenting with Plasmacytoid Morphology and BRAF V600 MutationLinda Kocovski, Anita Bane, Shangguo Tang, et al.
Scientific Reports|May 1, 2019
Downregulation of CYB5D2 is associated with breast cancer progressionDiane Ojo, David Rodriguez, Fengxiang Wei, et al.
Scientific Reports|February 23, 2012
A gene signature for predicting outcome in patients with basal-like breast cancerRobin M Hallett, Anna Dvorkin-Gheva, Anita Bane, et al.
Cancer Letters|April 8, 2018
Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancerDiane Ojo, Xiaozeng Lin, Ying Wu, et al.
Nature Reviews. Clinical Oncology|September 30, 2009
Breast cancer in a BRCA2 mutation carrier with a history of prostate cancerSeema Panchal, Orli Shachar, Frances O'Malley, et al.
Breast Cancer Research and Treatment|July 2, 2013
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancersAnita Bane, Alicia Viloria-Petit, Dushanthi Pinnaduwage, et al.
Pageof 4